✦ LIBER ✦

Lymphocyte deactivation by (potential immunosuppressant) alkylating metabolites of cyclophosphamide

✍ Scribed by Michael W. Whitehouse; Frances W. J. Beck; Marlies M. Dröge; Robert F. Struck

Publisher: SP Birkhäuser Verlag Basel
Year: 1974
Tongue: English
Weight: 597 KB
Volume: 4
Category: Article
ISSN: 1420-908X
DOI: 10.1007/bf01966821

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction in vitro of reversible immunos

Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide

✍ F. L. Shand; J. G. Howard 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Inhibition of human B lymphocyte differe

Inhibition of human B lymphocyte differentiation by a stable metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide)

✍ Andrzej Gorski; Grażyna Korczak-Kowalska 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 194 KB

We have evaluated the immunosuppressive effect of a new stable derivative of cyclophosphamide (ASTA Z 7557) on human lymphocyte immunoglobulin biosynthesis in vitro. When graded amounts of the drug are added to lymphocyte cultures stimulated with the helper T cell-dependent activator (PWM), a marked

Phenotypes associated with tumor rejecti

Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized t lymphocytes: Potential mechanisms of action

✍ Robert Evans 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 926 KB

## Abstract The phenotypes of the affector and effector cell populations involved during the induction of permanent tumor regression by combined therapy using cyclophosphamide (CY) and immune spleen cells were identified. Permanent tumor regression was dependent on the presence of Thy‐1^+^ Lyt‐2^+^